Publication of Study Results

Sequana Medical Announces Publication of Results of Multicentre Randomized Controlled Study for the alfapump(R) vs. Large Volume Paracentesis for Refractory Ascites in Journal of Hepatology

Zurich, SWITZERLAND 06. July 2017 -- Sequana Medical AG (“Sequana Medical), a commercial stage medical device company and an innovator in the management of liver disease, announces the publication of a multicentre, randomized controlled trial in the Journal of Hepatology (http://www.journal-of-hepatology.eu/article/S0168-8278(17)32080-9/ppt).

The study demonstrated that in patients with refractory ascites, the alfapump®:

  • significantly reduces the requirement for LVP compared to standard of care
  • significantly improves Health-Related Quality of Life compared to standard of care
  • shows nutritional benefits compared to standard of care

View full press release